These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 6241751)
1. Abnormal haemostasis and blood viscosity in malignant hypertension. Isles C; Lowe GD; Rankin BM; Forbes CD; Lucie N; Lever AF; Kennedy AC Thromb Haemost; 1984 Dec; 52(3):253-5. PubMed ID: 6241751 [TBL] [Abstract][Full Text] [Related]
2. Blood viscosity and haemostasis in the nephrotic syndrome. McGinley E; Lowe GD; Boulton-Jones M; Forbes CD; Prentice CR Thromb Haemost; 1983 Jun; 49(3):155-7. PubMed ID: 6410531 [TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy. Roy MS; Podgor MJ; Rick ME Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258 [TBL] [Abstract][Full Text] [Related]
4. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Ben-Ari Z; Osman E; Hutton RA; Burroughs AK Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855 [TBL] [Abstract][Full Text] [Related]
5. [The hemostasis parameters and ACE gene polymorphism in patients with essential hypertension treated with perindopril]. Janczak-Bazan A Ann Acad Med Stetin; 2006; 52(1):51-61; discussion 61-2. PubMed ID: 17131847 [TBL] [Abstract][Full Text] [Related]
6. Decreased blood viscosity and serum levels of erythropoietin after anti-hypertensive treatment with amlodipine or metoprolol: results of a cross-over study. Linde T; Sandhagen B; Hägg A; Mörlin C; Danielson BG J Hum Hypertens; 1996 Mar; 10(3):199-205. PubMed ID: 8733040 [TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
8. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
9. [Coagulation tests in septic surgical patients]. Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805 [TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related]
11. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report. Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773 [TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer. Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184 [TBL] [Abstract][Full Text] [Related]
13. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. Islim IF; Bareford D; Beevers DG Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379 [TBL] [Abstract][Full Text] [Related]
14. Hemostasis during normal pregnancy and puerperium. Hellgren M Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915 [TBL] [Abstract][Full Text] [Related]
15. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment. Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745 [TBL] [Abstract][Full Text] [Related]
16. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension. Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities in thrombogenic and rheologic factors in Nigerian hypertensive patients. Ogunlade OA; Fasanmade AA Afr J Med Med Sci; 2001 Dec; 30(4):291-4. PubMed ID: 14510106 [TBL] [Abstract][Full Text] [Related]